100
Participants
Start Date
June 30, 2024
Primary Completion Date
May 31, 2026
Study Completion Date
May 31, 2026
Placebo 1 to Probiotic A
42 day Crossover study design between Placebo 1 and Probiotic A (n = 25)
Probiotic A to Placebo 1
42 day Crossover study design between Probiotic A and Placebo 1 (n = 25)
Placebo 2 to Probiotic B
42 day Crossover study design between Placebo 2 and Probiotic B (n = 25)
Probiotic B to Placebo 2
42 day Crossover study design between Probiotic B and Placebo 2 (n = 25)
Merieux NutriSciences (China)
UNKNOWN
The Archer-Daniels-Midland Company
INDUSTRY